The best way to invest in
Pharmaceuticals
Access global pharmaceutical companies developing and commercialising prescription drugs across therapeutic areas. Pharmaceutical equities offer patent-protected revenue streams, high barriers to entry, and steady demand regardless of economic conditions.
Read more
10.4%* 5Y annualised returns
26 global pharmaceutical companies
Sign up and invest with free buy orders
We’re licensed by the Securities Commission Malaysia (Licence eCMSL/A0352/2018)
RETURNS DATA
Invest in the companies developing tomorrow's medicines: 10.4%* 5Y annualised returns
If you had invested in the Pharmaceuticals from July 2021 to July 2026, your money could have grown by around 65%.
1 Year Returns
Loading...
Loading...
Loading...
Disclaimer
Create your Pharmaceuticals portfolio
StashAway ETF Explorer is the smart way to invest in 90+ global asset classes, including Pharmaceuticals.
It's cost-effective
- Start investing today to get unlimited free buy orders for your next month.
- After, it's only $1.99 USD per buy or sell order, excluding SST.
- No additional management fee, no matter how much you invest.
It's simple
- Build your portfolio in as little as 1 minute.
- Automate recurring investments for ease of mind.
- No minimum balance, no lock-ins, and high liquidity mean you can access your funds anytime.
It's intelligent
- Our investment team analyses thousands of ETFs to identify cost-efficient, tax-efficient, and well-managed options.
- We swap underlying ETFs if a better alternative surfaces, saving you more over time.
It's cost-effective
- Start investing today to get unlimited free buy orders for your next month.
- After, it's only $1.99 USD per buy or sell order, excluding SST.
- No additional management fee, no matter how much you invest.
It's simple
- Build your portfolio in as little as 1 minute.
- Automate recurring investments for ease of mind.
- No minimum balance, no lock-ins, and high liquidity mean you can access your funds anytime.
It's intelligent
- Our investment team analyses thousands of ETFs to identify cost-efficient, tax-efficient, and well-managed options.
- We swap underlying ETFs if a better alternative surfaces, saving you more over time.
GET STARTED WITH FREE BUY ORDERS
Own pharmaceutical stocks with one investment
Invest in the companies creating the medicines that extend and improve lives
Asset Class Overview
Pharmaceuticals Snapshot
Key information across returns, asset class profile, and investment details.
Returns
Annualised since inception
+10.06%
Since 31 December 2011
5-year annualised
+10.42%
Since 30 June 2021
1-year annualised
+25.99%
Since 30 June 2025
Year-to-date
+6.90%
Since 2026
Positive years since inception
85.71%
of calendar years
Fund Profile
Asset type
Equities
Fund inception
2011
Fundamentals
Expense ratio
0.36%
Annual ETF expense ratio
1-year dividend yield
2.00%
Trailing 12-month yield
Currency denomination
USD
US Dollar
Disclaimer
RETURNS DATA
Annual returns since 2011
Growth driven by the world's leading pharmaceutical companies
Did you know?
A major pharmaceutical drug takes an average of 10-15 years and $1-3 billion in research and development expenditure to bring from initial discovery to regulatory approval — a process with a very high failure rate, as fewer than 10% of drugs entering clinical trials ultimately receive approval. Once approved, a successful drug can generate billions in annual revenue before generic competition enters following patent expiry, typically 10-20 years after initial filing. The pharmaceutical industry's patent 'cliff' — periods when multiple major drugs lose exclusivity simultaneously — creates predictable earnings pressure that drives the sector's constant pursuit of new molecule development and acquisition.
PORTFOLIO BREAKDOWN
Sector exposure
Consumer, Non-cyclical
100.0%
Source: Bloomberg. Weights are approximate and subject to change on index rebalance.
PORTFOLIO BREAKDOWN
Geographic exposure
EXPLORE MORE
Other asset classes available
Other investors who viewed Pharmaceuticals also explored these
